Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

SHE:300942 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	249.41	221.82	243.57	676.32	583.14	236.1
Other Revenue	2.43	2.43	10.54	10.58	14.4	22.35
Revenue	251.83	224.25	254.11	686.9	597.54	258.46
Revenue Growth (YoY)	1.93%	-11.75%	-63.01%	14.95%	131.20%	8.06%
Cost of Revenue	80.82	68.15	157.92	345.01	171.38	76.73
Gross Profit	171.02	156.1	96.19	341.89	426.16	181.73
Selling, General & Admin	101.02	95.23	151.18	151.19	100.05	72.5
Research & Development	42.47	40.45	53.14	111.42	72.43	38.89
Other Operating Expenses	8.59	-3.09	3.52	2.51	3.16	1.71
Operating Expenses	155.61	140.73	210.66	269.13	178.05	115.4
Operating Income	15.4	15.38	-114.47	72.76	248.1	66.33
Interest Expense	-26.26	-18.67	-10.63	-4.08	-2.38	-0.37
Interest & Investment Income	9.52	8.33	7.56	6.24	6.6	9.2
Currency Exchange Gain (Loss)	2.65	2.65	6.03	9.23	-4.14	-10.49
Other Non Operating Income (Expenses)	4.63	0.06	-0.88	-0.22	-0.67	-0.43
EBT Excluding Unusual Items	5.94	7.75	-112.39	83.93	247.51	64.24
Gain (Loss) on Sale of Investments	-1.73	-3.98	-54.08	-	5.21	-
Gain (Loss) on Sale of Assets	11.96	2.28	2.81	1.43	-	-
Asset Writedown	-1.12	-1.16	-26.15	-1.95	-0	-0.01
Other Unusual Items	16.79	14.67	12.01	11.47	15.32	9.72
Pretax Income	31.96	19.69	-177.8	94.89	268.04	73.94
Income Tax Expense	-0.48	3.07	7.19	12.22	31.57	8.49
Earnings From Continuing Operations	32.44	16.62	-184.98	82.66	236.47	65.45
Minority Interest in Earnings	-1.2	0.5	0.08	0.3	0.04	-0
Net Income	31.24	17.12	-184.91	82.97	236.51	65.45
Net Income to Common	31.24	17.12	-184.91	82.97	236.51	65.45
Net Income Growth	-	-	-	-64.92%	261.38%	-29.10%
Shares Outstanding (Basic)	428	428	402	395	394	364
Shares Outstanding (Diluted)	428	428	402	395	394	364
Shares Change (YoY)	6.20%	6.45%	1.75%	0.23%	8.42%	2.41%
EPS (Basic)	0.07	0.04	-0.46	0.21	0.60	0.18
EPS (Diluted)	0.07	0.04	-0.46	0.21	0.60	0.18
EPS Growth	-	-	-	-65.00%	233.33%	-30.77%
Free Cash Flow	-72.88	-139.85	-165.89	-24.29	175.92	-19.04
Free Cash Flow Per Share	-0.17	-0.33	-0.41	-0.06	0.45	-0.05
Dividend Per Share	0.017	0.017	-	0.021	0.249	0.045
Dividend Growth	-	-	-	-91.49%	453.33%	-
Gross Margin	67.91%	69.61%	37.85%	49.77%	71.32%	70.31%
Operating Margin	6.12%	6.86%	-45.05%	10.59%	41.52%	25.66%
Profit Margin	12.41%	7.63%	-72.77%	12.08%	39.58%	25.32%
Free Cash Flow Margin	-28.94%	-62.36%	-65.29%	-3.54%	29.44%	-7.37%
EBITDA	26.77	28.69	-98.56	84.22	257.12	71.84
EBITDA Margin	10.63%	12.79%	-38.79%	12.26%	43.03%	27.80%
D&A For EBITDA	11.37	13.31	15.91	11.46	9.01	5.52
EBIT	15.4	15.38	-114.47	72.76	248.1	66.33
EBIT Margin	6.12%	6.86%	-45.05%	10.59%	41.52%	25.66%
Effective Tax Rate	-	15.59%	-	12.88%	11.78%	11.49%
Revenue as Reported	251.83	224.25	254.11	686.9	597.54	258.46
Advertising Expenses	-	0.13	0.96	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.